By investing through the Principia III - Health Fund, Principia SGR has bought a USD 7.2 million stake in CrestOptics SpA, an Italian hight-tech company founded in 2012 which operates in the field of experimental research and dedvelopment as well as electro-optical technologies applied to biolofy and material sciences.

 

Download the PDF for the full press release